Bio atenolol 50?

See the DrugPatentWatch profile for atenolol

What is the patent status of Atenolol 50mg in the United States?

According to the patent database DrugPatentWatch.com, Atenolol 50mg tablets in the United States are protected by a patent filed by Boehringer Ingelheim Pharmaceuticals, Inc. However, the patent expired in 2001 [1].

Are there any generic versions available?

Yes, many generic versions of Atenolol 50mg are available in the market. Since the patent has expired, several manufacturers have developed and are marketing generic versions of the medication.

How does the generic version differ from the branded version?

The generic version of Atenolol 50mg is bioequivalent to the branded version, meaning that it has the same active ingredient and works in the same way. The FDA requires that generic medications meet the same standards for quality, purity, and potency as the branded version [2].

What are the potential benefits of using a generic version of Atenolol 50mg?

Using a generic version of Atenolol 50mg may have several benefits, including cost savings and increased availability. Generic medications are often significantly cheaper than branded medications, making them a more affordable option for patients [3].

References:

[1] DrugPatentWatch.com. (n.d.). US Patent 4441858. Retrieved from https://www.drugpatentwatch.com/patent/US-4441858/

[2] FDA. (n.d.). Bioequivalence and Bioavailability. Retrieved from https://www.fda.gov/drugs/bioequivalence-and-bioavailability

[3] Generic Pharmaceutical Association. (n.d.). The Benefits of Generic Medications. Retrieved from https://www.genpharma.org/benefits

Additional resources:

For more information on Atenolol 50mg, its patent status, and generic versions, you can visit the following websites:

- National Institutes of Health (NIH)
- FDA.gov
- DrugPatentWatch.com
- Generic Pharmaceutical Association (GPhA)